DUBLIN--(BUSINESS WIRE)--The "Cell Expansion Market by Product, by Cell Type, by Application, by End-User and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The global cell expansion market size is estimated to be USD 15.82 billion in 2021 and is expected to witness a CAGR of 12.85% during the forecast period. Increasing prevalence of chronic diseases, investment opportunities in cell-based therapy and biotechnology industry, rise in the use of the automated solutions for the purpose of cell expansion major factor that boosts the global market growth.
Also, the preference for gene therapy and use of biologics are some of the other factors that help in the growth during the forecast period. However, the risk of toxicity in animals and human beings in the course of research along with the ethical concerns with cell biology research are some of the factors hindering the market growth.
Based on the product, the global market is segmented into consumables, culture flasks and accessories and accessories, and instruments. In 2021, the consumables segment accounted for the largest revenue share owing to the rise in the demand for vaccines and other biopharmaceuticals, like biologic drugs for cancer treatment. However, the instruments segment is estimated to grow at the highest CAGR during the forecast period. This can be attributed to the automation of the bioreactors leading to high-efficiency performance.
By Cell Type
Based on the technique, the market is categorized into mammalian and microbial cells majorly. In 2021, the mammalian cells segment accounted for their high similarity to humans and hence can be used for various pharmacokinetic research. Human stem cells are having high demand and expected to post the highest growth rate in the forecast period due to the use of regenerative medicine and personalized medications in the medical research arena. The differentiated human cells have gained market share due to the demand rise in skin engineering.
By Application
Based on the application, the market is divided into biopharmaceutical, tissue culture, vaccine production, drug development. The biopharmaceutical segment was the highest revenue-grossing segment in 2021. This is due to the approval of biopharmaceutical product approval in the past years. Single-use technologies are gaining importance because of the increase in cell-based therapies. The vaccine segment will post the highest growth rate in the forecast period owing to the high adoption of cell-based therapy and regenerative medications among the patients.
By End-User
Based on end-user, biopharmaceuticals, research institutes, and cell banks are some of the important segments. The biopharmaceutical segment was the highest revenue grossing segment in 2021 due to the high preference for cell-based therapy in place of the traditional injectables for drug delivery. Inorganic growth is also taking place in the segment. Such as in 2021, Sartorius AG is in the process of acquisition of 50% of Biological Industries, which is into the cell culture manufacturing industry. The research institutes are expected to post the highest rate of growth and it may be attributed to a high number of researches that are happening in the biopharmaceutical field.
Market Segmentation
Cell Expansion Market, By Product (Revenue, 2021 - 2029, USD Billion)
-
Consumables
- Reagents, media, & serum
- Other consumables
-
Culture flasks and accessories
- Tissue Culture Flasks
- Bioreactor Accessories
- Others
- Automated Cell Expansion Systems
- Cell Counters
- Centrifuges
- Bioreactors
- Others
Cell Expansion Market, By Cell Type (Revenue, 2021 - 2029, USD Billion)
- Mammalian Cells
- Human Cells
- Stem Cells
- Adult Stem Cells
- Induced Pluripotent Stem Cells
- Embryonic Stem Cells
- Differentiated Cells
- Animal Cells
- Microbial Cells
- Others
Cell Expansion Market, By Application (Revenue, 2021 - 2029, USD Billion)
- Biopharmaceuticals
- Tissue Culture & Engineering
- Vaccine Production
- Drug Development
- Gene Therapy
- Cancer Research
- Stem Cell Research
- Other Applications
Cell Expansion Market, By End-User (Revenue, 2021 - 2029, USD Billion)
- Biotechnology and biopharmaceutical companies
- Research Institutes
- Cell Banks
- Others
Blood Culture Tests Market, By Region (Revenue, 2021 - 2029, USD Billion)
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- Australia
- South Korea
- India
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
South Africa
- Saudi Arabia
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Cell Expansion
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Cell Expansion Market
7. Market Analysis by Product
8. Market Analysis by Cell Type
9. Market Analysis by Application
10. Market Analysis by End user
11. Regional Market Analysis
12. North America Cell Expansion Market
11. Europe Cell Expansion Market
12. Asia Pacific Cell Expansion Market
13. Latin America Cell Expansion Market
14. MEA Cell Expansion Market
15. Competitor Analysis
16. Company Profiles
17. Conclusion & Recommendations
Companies Mentioned
- Thermo Fisher Scientific (U.S.)
- Lonza (Switzerland)
- Danaher (U.S.)
- Corning (U.S.)
- Becton
- Dickinson and Company (U.S.)
- Merck (Germany)
- STEMCELL Technologies Inc. (Canada)
- Terumo (Japan)
- Miltenyi Biotec (Germany)
- Sartorius Stedim Biotech (France)
For more information about this report visit https://www.researchandmarkets.com/r/s4yxkd
